Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | COMT | P21964 | 1/20 | 0.38 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | SSTR4 | P31391 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19767079 | 0.91 | COMT (0.39) | COMTTDP2KDM4EMAPTTDP1 | |
| SCHEMBL20626878 | 0.87 | AAK1 (0.34) | COMTKDM4EMAPTTDP1MEN1 | |
| SCHEMBL17992187 | 0.86 | SLC22A12 (0.36) | COMTKDM4EMEN1KMT2ASCN9A | |
| SCHEMBL20626880 | 0.85 | PLCG1 (0.32) | COMT | |
| SCHEMBL17992235 | 0.80 | CYP4F2 (0.34) | COMT | |
| SCHEMBL19767080 | 0.78 | COMT (0.35) | COMTTDP2KDM4EMAPTTDP1 | |
| SCHEMBL22518699 | 0.78 | DGAT1 (0.35) | COMTCNR2 | |
| SCHEMBL19767069 | 0.78 | AAK1 (0.35) | COMTKDM4EMAPTTDP1MEN1 | |
| SCHEMBL29672225 | 0.78 | DGAT1 (0.35) | COMTCNR2 | |
| SCHEMBL18908813 | 0.77 | COMT (0.32) | COMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| WO-2017073733-A1 | PEST CONTROL COMPOSITION AND USE THEREOF | 住友化学株式会社 | 2017-05-04 | — | — | WO | disclosed |
| WO-2016121969-A1 | BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | 住友化学株式会社 | 2016-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10173997-B2 | Bipyridine compound and use of same for noxious arthropod control | BBOX1, ACHE, MORF4L1 | COMT 1430/4885TDP2 3904/4885CNR2 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.